Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 3Withdrawn 1Suspended 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1Lymphoid 1Gynecologic 1Endocrine 1

Conditions

Solid Tumors 4Mesothelioma 4Solid Tumor 3Neoplasms 3Mesothelioma, Malignant 3Unspecified Adult Solid Tumor, Protocol Specific 2Small Cell Lung Carcinoma 2Advanced Solid Tumor 2Advanced Refractory Solid Tumors 2Uterine Cervical Neoplasms 1Solid Tumor, Childhood 1Psoriasis 1Prostatic Neoplasms 1Post-Lyme Disease Syndrome 1Parkinson Disease 1Obsessive-Compulsive Disorder 1Myasthenia Gravis 1Multiple Sclerosis, Relapsing-Remitting 1Multiple Sclerosis, Chronic Progressive 1Multiple Sclerosis 1Migraine Disorders 1Malignant Solid Neoplasm 1Lyme Neuroborreliosis 1Lyme Disease 1Lung Neoplasms 1Irritable Bowel Syndrome 1Hypercholesterolemia 1Hodgkin Disease 1Hematopoietic and Lymphoid System Neoplasm 1Hematopoietic and Lymphatic System Neoplasm 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Carcinoma, Neuroendocrine × Other solid neoplasm × Clear all
NCT05337735 2026-05-04

A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers

M.D. Anderson Cancer Center

Phase 2 Suspended
140 enrolled
EndocrineGynecologicLymphoidOther solid neoplasmThoracic

Mesothelioma, Malignant, Uterine Cervical Neoplasms, Hodgkin Disease, Carcinoma, Neuroendocrine, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡